Prescription

MRD / Regn No.

: THBC\23-24\08040

Date

: 23/06/2026

Patient Name

: Narendra Kekan

Age & Gender

: 73 Yrs. / Male

Contact No.

: 8108502030

UHID

Ht / Wt / BMI

BP S / BP D

Allergies

: NONE

Referred By

Problem List	:	T2DM (22/Oct/2012) \|
Subjective	:	T2DM SINCE 2012,RECENTLY DIAGNOSED AS ALZHEIMER'S DISEASE,ALZIL 5 MG / 2B12,LOST BROTHER TO LIVER CANCER,SWELLING OVER FEET / ESP ON PROLONGED SITTING,SLEEP DISTURBED - OFTEN ALL NIGHT,BUT NOT COMFORTABLE WITH MEDS FOR SLEEP
Objective	:	21-JUN-2026 REPORTS,FBS-165.50/ PPBS-212.10,HBA1C-9.0%
Plan	:	RISK OF HYPOGLYCEMIA OUTWEIGHS THE BENEFIT OF KEEPING HBA1C AT LOWER NUMBER TO REDUCE RISK OF COMPLICATIONS

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	TABLET VILDAGLIPTIN METFORMIN 50/1000 MG JALRA M 50/1000	ORAL	1-0-1	BBF / BD	8 MTHS

2	SHELCAL 500 MG	ORAL	0-0-1	AD	TO CONTINUE

3	TABLET CHOLECALCIFEROL 60,000IU DRISE 60K	ORAL	1 /15 DAYS	ANYTIME OF DAY	TO CONTINUE

4	2B12	ORAL	0-1-0	AL	8 MTHS

Refill : 0 / Substitution:

Education

: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.

Next Visit

: 24/Oct/2026

Tests Suggested For Next Visit

: HBA1C > 4 MTHS - TEXT ME - IF HBA1C CLOSE TO 8% - NO VISIT NEEDED - CT SAME MEDS,AFTER 8 MTHS - HBA1C / FBS / PPBS,EYE TEST FOR DIABETIC RETINOPATHY